Research menu
Jump to menu

Publications:  Prof Hemant Kocher

McCluney S, Wijesuriya N, Sheshappanavar V et al.(2018). Solid pseudopapillary tumour of the pancreas: clinicopathological analysis. ANZ J Surg vol. 88, (9) 891-895.
McCluney SJ, Giakoustidis AA, Segler A et al.(2018). Predicting complications in hepatic resection for colorectal liver metastasis: the lymphocyte-to-monocyte ratio. ANZ J Surg
McCluney SJ, Giakoustidis A, Segler A et al.(2018). Neutrophil: Lymphocyte ratio as a method of predicting complications following hepatic resection for colorectal liver metastasis. J Surg Oncol vol. 117, (5) 1058-1065.
Ghaneh P, Hanson R, Titman A et al.(2018). PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer. Health Technol Assess vol. 22, (7) 1-114.
Neuzillet C, de Mestier L, Rousseau B et al.(2018). Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers part 2: Neuroendocrine tumours, hepatocellular carcinoma, and gastro-intestinal stromal tumours. Pharmacol Ther vol. 181, 49-75.
Pearce OMT, Delaine-Smith R, Maniati E et al.(2017). Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers. Cancer Discov
CRNOGORAC-JURCEVIC T(2017). Non-invasive Diagnosis of Pancreatic Cancer Through Detection of Volatile Organic Compounds in Urine. Gastroenterology
Marzec J, Dayem Ullah AZ, Pirrò S et al.(2017). The Pancreatic Expression Database: 2018 update. Nucleic Acids Res vol. 46, (D1) D1107-D1110.
Veenstra VL, Damhofer H, Waasdorp C et al.(2017). Stromal SPOCK1 supports invasive pancreatic cancer growth. Mol Oncol vol. 11, (8) 1050-1064.
Neuzillet C, Rousseau B, Kocher H et al.(2017). Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers Part 1: GI carcinomas. Pharmacol Ther vol. 174, 145-172.
McCluney SJ, Jamalfar A, Abraham AT et al. (2017). Surgical referrals at a major trauma centre: an unsustainable future?. BRITISH JOURNAL OF SURGERY. vol. 104, 41-41.
Kadaba RS, Bowers KA, Khorsandi S et al.(2017). Complications of biliary-enteric anastomoses. Ann R Coll Surg Engl vol. 99, (3) 210-215.
King H, Thillai K, Whale A et al.(2017). PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration. Sci Rep vol. 7, 42575-42575.
Arumugam P, Bhattacharya S, Chin-Aleong J et al.(2017). Expression of polymeric immunoglobulin receptor and stromal activity in pancreatic ductal adenocarcinoma. Pancreatology vol. 17, (2) 295-302.
Solaini L, Atmaja BT, Arumugam P et al.(2016). The role of perioperative inflammatory-based prognostic systems in patients with colorectal liver metastases undergoing surgery. A cohort study. Int J Surg vol. 36, (Pt A) 8-12.
Hariharan D, Junaid H, Bhattacharya S et al. (2016). Accuracy of EUS/FNAC in the management of solid, cystic and mixed lesions affecting the pancreas. BRITISH JOURNAL OF SURGERY. vol. 103, 8-8.
McCluney SJ, Balarajah V, Giakoustidis A et al.(2016). Intussuscepting Ampullary Adenoma: An Unusual Cause of Gastric Outlet Obstruction Leading to Cavitating Lung Lesions. Case Reports in Gastroenterology vol. 10, (3) 545-552.
Balarajah V, Ambily A, Dayem Ullah AZ et al.(2016). Pancreatic cancer tissue banks: where are we heading?. Future Oncol vol. 12, (23) 2661-2663.
Carapuça EF, Gemenetzidis E, Feig C et al.(2016). Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma. Journal of Pathology vol. 239, (3) 286-296.
GROSE RP, Dawkins JBN, Wang J et al.(2016). Reduced expression of histone methyltransferases KMT2C and KMT2D correlates with improved outcome in pancreatic ductal adenocarcinoma. Cancer Research
Di Maggio F, Arumugam P, Delvecchio FR et al.(2016). Pancreatic stellate cells regulate blood vessel density in the stroma of pancreatic ductal adenocarcinoma. Pancreatology
Ghaneh P, Wong WL, Titman A et al. (2016). PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer. JOURNAL OF CLINICAL ONCOLOGY. vol. 34,
Arumugam P, Balarajah V, Watt J et al.(2016). Role of laparoscopy in hepatobiliary malignancies. Indian J Med Res vol. 143, (4) 414-419.
Coupland VH, Konfortion J, Jack RH et al.(2016). Resection rate, hospital procedure volume and survival in pancreatic cancer patients in England: Population-based study, 2005-2009. Eur J Surg Oncol vol. 42, (2) 190-196.
Arumugam P, Fletcher N, Kyriakides C et al.(2016). Lymphoepithelial Cyst of the Pancreas. Case Rep Gastroenterol vol. 10, (1) 181-192.
Pantelidou C, Man YKS, Coughlan L et al.(2016). Oncolytic adenoviral mutants deleted in the anti-apoptotic E1B19K gene sensitize pancreatic cancer cells to drug-induced DNA damage. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE vol. 38, S58-S58.
Balarajah V, Neuzillet C, Kocher HM(2016). Targeting pancreatic stellate cells to improve pancreatic cancer radiosensitivity. Translational Cancer Research vol. 5, S730-S737.
Alison M, Cereser B, Kocher H et al. (2015). Clonal analysis of the human liver reveals adaptable stem cell dynamics. HEPATOLOGY. vol. 62, 260A-260A.
Radon TP, Massat NJ, Jones R et al.(2015). Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma. Clin Cancer Res vol. 21, (15) 3512-3521.
Reader CS, Vallath S, Morton J et al. (2015). Cell lines generated from PDAC transgenic mice reveal integrin alpha v beta 6 modifies the invasive phenotype of pancreatic cancer. CANCER RESEARCH. vol. 75,
Carapua EF, Gemenetzidis E, Feig C et al. (2015). Developing drug combinations to co-target pancreatic cancer and its supporting stroma. CANCER RESEARCH. vol. 75,
Watt J, Siddique I, Dowe T et al. (2015). The role of Pentraxin 3 (PTX3) in pancreatic ductal adenocarcinoma. CANCER RESEARCH. vol. 75,
Solaini L, Atmaja BT, Watt J et al.(2015). Limited utility of inflammatory markers in the early detection of postoperative inflammatory complications after pancreatic resection: Cohort study and meta-analyses. Int J Surg vol. 17, 41-47.
Solaini L, Jamieson NB, Metcalfe M et al.(2015). Outcome after surgical resection for duodenal adenocarcinoma in the UK. Br J Surg vol. 102, (6) 676-681.
Viloria K, Ryall C, Dandagama A et al. (2015). Creating a 3D matricellular environment to promote islet expansion for diabetes therapy - the role of SPARC family proteins. FASEB JOURNAL. vol. 29,
Froeling FEM, Kocher HM(2015). Homeostatic restoration of desmoplastic stroma rather than its ablation slows pancreatic cancer progression. Gastroenterology vol. 148, (4) 849-850.
Wong P-P, Demircioglu F, Ghazaly E et al.(2015). Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread. Cancer Cell vol. 27, (1) 123-137.
Debernardi S, Massat NJ, Radon TP et al.(2015). Noninvasive urinary miRNA biomarkers for early detection of pancreatic adenocarcinoma. Am J Cancer Res vol. 5, (11) 3455-3466.
Ryall CL, Viloria K, Lhaf F et al.(2014). Novel role for matricellular proteins in the regulation of islet β cell survival: the effect of SPARC on survival, proliferation, and signaling. J Biol Chem vol. 289, (44) 30614-30624.
Sunkel-Laing B, Kalam A, Renfrew I et al.(2014). Repeated negative biopsies in isolated high-grade cystic duct dysplasia with progression to adenocarcinoma. Case Rep Gastroenterol vol. 8, (2) 304-309.
Coleman SJ, Bruce C, Chioni A-M et al.(2014). The ins and outs of fibroblast growth factor receptor signalling. Clin Sci (Lond) vol. 127, (4) 217-231.
Konfortion J, Coupland VH, Kocher HM et al.(2014). Time and deprivation trends in incidence of primary liver cancer subtypes in England. J Eval Clin Pract vol. 20, (4) 498-504.
Coleman SJ, Watt J, Arumugam P et al.(2014). Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluation. World J Gastroenterol vol. 20, (26) 8471-8481.
Gill RMS, Michael A, Westley L et al.(2014). SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression. Experimental Cell Research vol. 324, (2) 157-171.
Gill RMS, Michael A, Westley L et al.(2014). SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression. Exp Cell Res vol. 324, (2) 157-171.
Solaini L, Sharma A, Watt J et al.(2014). Predictive factors for incidental gallbladder dysplasia and carcinoma. J Surg Res vol. 189, (1) 17-21.
Carapuca E, Gemenetzidis E, Feig C et al. (2014). Developing Drug Combinations to Co-Target Pancreatic Cancer and Its Supporting Stroma. GASTROENTEROLOGY. vol. 146, S498-S498.
Watt J, Siddiqui I, Radon T et al. (2014). Pentraxin3 Is a Stromal Biomarker in Pancreatic Ductal Adenocarcinoma. GASTROENTEROLOGY. vol. 146, S276-S276.
Solaini L, Jamieson NB, Tamburrini R et al. (2014). UK Multicentre Surgical Experience With Primary Duodenal Adenocarcinoma. GASTROENTEROLOGY. vol. 146, S334-S334.
Coleman SJ, Chioni A-M, Ghallab M et al.(2014). Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion. EMBO Mol Med vol. 6, (4) 467-481.
Vyas S, Markar S, Partelli S et al.(2014). Portal vein embolization and ligation for extended hepatectomy. Indian J Surg Oncol vol. 5, (1) 30-42.
Watt J, Siddique I, Dowe T et al.(2014). Role of PTX3 in pancreatic cancer. LANCET vol. 383, 106-106.
Haider S, Wang J, Nagano A et al.(2014). A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma. Genome Med vol. 6, (12)
Coleman SJ, Grose RP, Kocher HM(2014). Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma. J Hepatocell Carcinoma vol. 1, 43-54.
Arumugam P, Partelli S, Coleman SJ et al.(2013). Ezrin expression is an independent prognostic factor in gastro-intestinal cancers. J Gastrointest Surg vol. 17, (12) 2082-2091.
Gourgiotis S, Gemenetzis G, Kocher HM et al.(2013). Permissive hypotension in bleeding trauma patients: helpful or not and when?. Crit Care Nurse vol. 33, (6) 18-24.
Watt J, Kocher HM(2013). The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration. Oncoimmunology vol. 2, (12)
Ene-Obong A, Clear AJ, Watt J et al.(2013). Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma. Gastroenterology vol. 145, (5) 1121-1132.
Sharma A, Iosifidou S, Qureishi A et al.(2013). Incidental gall bladder dysplasia and neoplasia in 21st century. Int J Surg vol. 11, (8)
Gabriel J, Graham TA, Kocher H et al. (2013). Methylation Patterns of Clonally-Related Hepatocytes Provide Evidence of a Periportal Stem Cell Niche in the Normal Human Liver. JOURNAL OF PATHOLOGY. vol. 231, 15-15.
Kadaba R, Birke H, Wang J et al.(2013). Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes. J Pathol vol. 230, (1) 107-117.
Coleman S, Chioni A-M, Ghallab M et al. (2013). Nuclear Translocation of FGFR1 and FGF2 in Pancreatic Stellate Cells Is Necessary for Pancreatic Cancer Cell Invasion. GASTROENTEROLOGY. vol. 144, S98-S98.
Ghallab MA, Rosignoli G, Escrig IS et al. (2013). Targeting pancreatic cancer stroma by HDAC inhibitors. BRITISH JOURNAL OF SURGERY. vol. 100, 4-4.
Jack RH, Konfortion J, Coupland VH et al.(2013). Primary liver cancer incidence and survival in ethnic groups in England, 2001-2007. Cancer Epidemiol vol. 37, (1) 34-38.
Milne R, La Vecchia C, Van Steen K et al.(2013). EU Pancreas: an integrated European platform for pancreas cancer research--from basic science to clinical and public health interventions for a rare disease. Public Health Genomics vol. 16, (6) 305-312.
Li NF, Gemenetzidis E, Marshall FJ et al.(2013). RhoC interacts with integrin α5β1 and enhances its trafficking in migrating pancreatic carcinoma cells. PLoS One vol. 8, (12)
Coward JIG, Ding N-L, Feakins R et al.(2012). Chemotherapy-induced bowel obstruction in small cell lung cancer: a case report. Med Oncol vol. 29, (4) 2623-2625.
Vyas S, Bent C, Partelli S et al.(2012). Portal vein embolisation for extended hepatectomy: single-centre experience. J Gastrointest Cancer vol. 43, (3) 413-419.
Coupland VH, Kocher HM, Berry DP et al.(2012). Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007. Cancer Epidemiol vol. 36, (4) e207-e214.
Guppy NJ, El-Bahrawy ME, Kocher HM et al.(2012). Trefoil factor family peptides in normal and diseased human pancreas. Pancreas vol. 41, (6) 888-896.
Hariharan D, Constantinides V, Kocher HM et al.(2012). The role of laparoscopy and laparoscopic ultrasound in the preoperative staging of patients with resectable colorectal liver metastases: a meta-analysis. Am J Surg vol. 204, (1) 84-92.
Naidoo K, Jones R, Dmitrovic B et al.(2012). Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and lymph node metastases. J Pathol vol. 226, (5) 756-763.
Lines KE, Chelala C, Dmitrovic B et al.(2012). S100P-binding protein, S100PBP, mediates adhesion through regulation of cathepsin Z in pancreatic cancer cells. Am J Pathol vol. 180, (4) 1485-1494.
Kocher HM, Kadaba R(2011). Chronic pancreatitis. BMJ Clin Evid vol. 2011,
Gadaleta E, Cutts RJ, Kelly GP et al.(2011). A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws. Nucleic Acids Res vol. 39, (18) 7900-7907.
Froeling FEM, Feig C, Chelala C et al.(2011). Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression. Gastroenterology vol. 141, (4) 1486-1497.14.
Coleman SJ, Myrto-Chioni A, Grose RP et al. (2011). Investigating the Role of FGF Signaling in Pancreatic Cancer. GASTROENTEROLOGY. vol. 140, S714-S714.
Froeling F, Chelala C, Clevers H et al. (2011). Retinoic Acid-Induced Stellate Cell Quiescence Results in Sfrp4 Secretion Which Abrogates Wnt-beta-Catenin Signalling Pathway Modulating Human Pancreatic Tumour Cell Behaviour. GASTROENTEROLOGY. vol. 140, S156-S157.
Kadaba R, Froeling F, Soylu E et al. (2011). The Ratio of Pancreatic Stellate Cells to Pancreatic Cancer Cells Plays a Critical Role in Modulating Carcinoma Cell Behaviour. GASTROENTEROLOGY. vol. 140, S713-S713.
Lines KE, Audi N, Chelala C et al.(2011). Role of S100PBP in pancreatic adenocarcinoma. CANCER RESEARCH vol. 71,
Kadaba R, Bowers KA, Wijesuriya N et al.(2011). An unusual cause of gastrointestinal bleeding: duodenal lipoma. Case Rep Gastroenterol vol. 5, (1) 183-188.
Naidoo K, Al-Rawashdeh W, Hart IR et al.(2011). The role of S100P expression in metastatic pancreatic ductal adenocarcinoma. CLIN EXP METASTAS vol. 28, (2) 165-165.
Soylu E, Junnarkar S, Kocher HM(2010). Recurrent indigestion in a young adult. Case Rep Gastroenterol vol. 4, (3) 518-523.
Edling CE, Selvaggi F, Buus R et al.(2010). Key role of phosphoinositide 3-kinase class IB in pancreatic cancer. Clin Cancer Res vol. 16, (20) 4928-4937.
Hariharan D, Constantinides VA, Froeling FEM et al.(2010). The role of laparoscopy and laparoscopic ultrasound in the preoperative staging of pancreatico-biliary cancers--A meta-analysis. Eur J Surg Oncol vol. 36, (10) 941-948.
Froeling FEM, Marshall JF, Kocher HM(2010). Pancreatic cancer organotypic cultures. J Biotechnol vol. 148, (1) 16-23.
Kocher HM, Alrawashdeh W(2010). Pancreatic cancer. BMJ Clin Evid vol. 2010,
Ahmed I, Fotiadis NI, Dilks P et al.(2010). Multiple intrahepatic artery aneurysms in a patient with Behçet's disease: use of transcatheter embolization for rupture. Cardiovasc Intervent Radiol vol. 33, (2) 398-401.
Lin W-R, Lim S-N, McDonald SAC et al.(2010). The histogenesis of regenerative nodules in human liver cirrhosis. Hepatology vol. 51, (3) 1017-1026.
Smith M, Kocher HM, Hunt BJ(2010). Aprotinin in severe acute pancreatitis. Int J Clin Pract vol. 64, (1) 84-92.
Partelli S, Mukherjee S, Mawire K et al.(2010). Larger hepatic metastases are more frequent with N0 colorectal tumours and are associated with poor prognosis: implications for surveillance. Int J Surg vol. 8, (6) 453-457.
Kocher HM, Dervenis C, Olah A et al. (2010). Nutrition in Acute Pancreatitis. PANCREATIC DISEASE: PROTOCOLS AND CLINICAL RESEARCH. Editors: Johnson, CD, Imrie, CW, 31-40.
Jawad N, Woolf AK, Chin-Aleong J-A et al.(2009). Biliary Cystadenoma Causing Obstructive Jaundice: Case Report and Literature Review. Case Rep Gastroenterol vol. 3, (3) 269-274.
Froeling FEM, Mirza TA, Feakins RM et al.(2009). Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, beta-catenin, and Ezrin expression in tumor cells. Am J Pathol vol. 175, (2) 636-648.
Mukherjee S, Kocher HM, Hutchins RR et al.(2009). Impact of hospital volume on outcomes for pancreaticoduodenectomy: a single UK HPB centre experience. Eur J Surg Oncol vol. 35, (7) 734-738.
Partelli S, Beg S, Brown J et al.(2009). Alteration in emergency theatre prioritisation does not alter outcome for acute appendicitis: comparative cohort study. World J Emerg Surg vol. 4,
Fellous TG, McDonald SAC, Burkert J et al.(2009). A methodological approach to tracing cell lineage in human epithelial tissues. Stem Cells vol. 27, (6) 1410-1420.
Fellous TG, Islam S, Tadrous PJ et al.(2009). Locating the stem cell niche and tracing hepatocyte lineages in human liver. Hepatology vol. 49, (5) 1655-1663.
Iype S, Mirza TA, Propper DJ et al.(2009). Neuroendocrine tumours of the gallbladder: three cases and a review of the literature. Postgrad Med J vol. 85, (1002) 213-218.
Li NF, Kocher HM, Salako MA et al.(2009). A novel function of colony-stimulating factor 1 receptor in hTERT immortalization of human epithelial cells. Oncogene vol. 28, (5) 773-780.
Kocher HM, Sandle J, Mirza TA et al.(2009). Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells. Gut vol. 58, (2) 271-284.
Iqbal N, Lovegrove RE, Tilney HS et al.(2009). A comparison of pancreaticoduodenectomy with extended pancreaticoduodenectomy: a meta-analysis of 1909 patients. Eur J Surg Oncol vol. 35, (1) 79-86.
Kocher HM, Froeling FE(2008). Chronic pancreatitis. BMJ Clin Evid vol. 2008,
Iqbal N, Lovegrove RE, Tilney HS et al.(2008). A comparison of pancreaticoduodenectomy with pylorus preserving pancreaticoduodenectomy: A meta-analysis of 2822 patients. EJSO-EUR J SURG ONC vol. 34, (11) 1237-1245.
Mohamedali A, Lea NC, Feakins RM et al.(2008). AKT1 (E17K) mutation in pancreatic cancer. TECHNOL CANCER RES T vol. 7, (5) 407-408.
Gourgiotis S, Kocher HM, Solaini L et al.(2008). Gallbladder cancer. Am J Surg vol. 196, (2) 252-264.
Weeks ME, Hariharan D, Petronijevic L et al.(2008). Analysis of the urine proteome in patients with pancreatic ductal adenocarcinoma. PROTEOM CLIN APPL vol. 2, (7-8) 1047-1057.
Mai-Phan TA, Patel B, Walsh M et al.(2008). Emergency room surgical workload in an inner city UK teaching hospital. World J Emerg Surg vol. 3,
Kocher H, Sandle J, Mirza TA et al.(2008). A novel interaction of ezrin with cortactin in podosomal rosette assembly in pancreatic cancer cells. GASTROENTEROLOGY vol. 134, (4) A288-A288.
Froeling FE, Mirza TA, Li NF et al.(2008). Organotypic culture modelling of pancreatic cancer. GASTROENTEROLOGY vol. 134, (4) A586-A586.
Li NF, Froeling FE, Hart IR et al.(2008). RhoC enhances pancreatic carcinoma cell migration by mediating integrin signaling and podosome formation. GASTROENTEROLOGY vol. 134, (4) A288-A288.
Al-Ghnaniem R, Camprodon RAM, Kocher HM et al.(2008). Strategy to reduce the risk of positive pancreatic resection margin at pancreatico-duodenectomy. ANZ J Surg vol. 78, (4) 237-239.
Kocher HM(2008). Chronic pancreatitis. Am Fam Physician vol. 77, (5) 661-662.
Hariharan D, Saied A, Kocher HM(2008). Analysis of mortality rates for gallbladder cancer across the world. HPB (Oxford) vol. 10, (5) 327-331.
Hariharan D, Saied A, Kocher HM(2008). Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford) vol. 10, (1) 58-62.
O'Sullivan A, Kocher HM(2007). Pancreatic cancer. BMJ Clin Evid vol. 2007,
Kocher HM, Sohail M, Benjamin IS et al.(2007). Technical limitations of lymph node mapping in pancreatic cancer. EJSO-EUR J SURG ONC vol. 33, (7) 887-891.
Kocher HM, Mears L, Lea NC et al.(2007). JAK V617F missense mutation is absent in pancreatic cancer. Gut vol. 56, (8) 1174-1175.
Germanos S, Gourgiotis S, Kocher HM(2007). Clinical update: early surgery for acute cholecystitis. Lancet vol. 369, (9575) 1774-1776.
Fellous TG, Britian M, Kocher H et al. (2007). Mitochondrial DNA mutations to investigate cell lineage relations in human liver. GASTROENTEROLOGY. vol. 132, A830-A830.
Baril P, Gangeswaran R, Mahon PC et al.(2007). Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene vol. 26, (14) 2082-2094.
Mukherjee S, Kocher HM, Hutchins RR et al.(2007). Palliative surgical bypass for pancreatic and peri-ampullary cancers. J Gastrointest Cancer vol. 38, (2-4) 102-107.
Kocher HM, Warwick J, Al-Ghnaniem R et al.(2006). Surgical dexterity after a 'night out on the town'. ANZ J SURG vol. 76, (3) 110-112.
Kocher HM, Senkus R, Al-Nawab M et al.(2005). Subcellular distribution of Ras GTPase isoforms in normal human kidney. NEPHROL DIAL TRANSPL vol. 20, (5) 886-891.
Kocher HM, Tekkis PP, Gopal P et al.(2005). Risk-adjustment in hepatobiliary pancreatic surgery. World J Gastroenterol vol. 11, (16) 2450-2455.
Loong TPF, Kocher HM(2005). Clinical presentation and operative repair of hernia of Morgagni. POSTGRAD MED J vol. 81, (951) 41-44.
Kocher HM, Senkus R, Moorhead J et al.(2005). Expression of Ras GTPase isoforms in normal and diseased pancreas. Pancreatology vol. 5, (2-3) 205-214.
Tekkis PP, Prytherch DR, Kocher HM et al.(2004). Development of a dedicated risk-adjustment scoring system for colorectal surgery (colorectal POSSUM). Br J Surg vol. 91, (9) 1174-1182.
Kocher HM, Moorhead J, Sharpe CC et al.(2003). Expression of Ras GTPases in normal kidney and in glomerulonephritis. Nephrol Dial Transplant vol. 18, (11) 2284-2292.
Tekkis PP, Kessaris N, Kocher HM et al.(2003). Author's reply: Evaluation of POSSUM and P-POSSUM scoring systems in patients undergoing colorectal surgery (Br J Surg 2003; 90 : 340-345). BRIT J SURG vol. 90, (8) 1021-1021.
Kocher HM, Mohamed SA, Tekkis PP et al. (2003). Prediction of mortality and morbidity in hepatopancreaticobiliary surgery. BRITISH JOURNAL OF SURGERY. vol. 90, 92-92.
Clarke HC, Kocher HM, Khwaja A et al.(2003). Ras antagonist farnesylthiosalicylic acid (FTS) reduces glomerular cellular proliferation and macrophage number in rat thy-1 nephritis. J Am Soc Nephrol vol. 14, (4) 848-854.
Kocher HM, Tekkis PP(2003). Surgical treatment of esophageal cancer. N Engl J Med vol. 348, (12) 1177-1179.
Tekkis PP, Kessaris N, Kocher HM et al.(2003). Evaluation of POSSUM and P-POSSUM scoring systems in patients undergoing colorectal surgery. Br J Surg vol. 90, (3) 340-345.
Kocher HM, Steward M, Leather AJM et al.(2002). Randomized clinical trial assessing the side-effects of glyceryl trinitrate and diltiazem hydrochloride in the treatment of chronic anal fissure (Br J Surg 2002; 89: 413-17) - Reply. BRIT J SURG vol. 89, (9) 1193-1194.
Kocher HM, Al-Ghnaniem R, Patel AG(2002). Surgical dexterity after a night out on the town. BRIT J SURG vol. 89, 17-17.
Kocher HMK, Codd J, Al-Nawab M et al.(2002). Differential expression of RAS isoforms in normal and malignant human pancreas: An in vivo immunohistochemical analysis. GASTROENTEROLOGY vol. 122, (4) A495-A495.
Al-Ghnaniem R, Kocher HMK, Portmann B et al.(2002). Improving diagnostic accuracy of frozen section of the pancreatic resection margin at pancreatico-duodenectomy by concurrent examination of the suspected pancreatic lesion. GASTROENTEROLOGY vol. 122, (4) A566-A566.
Kocher HMK, Sohail M, Benjamin IS et al.(2002). Lymph node mapping in pancreatic cancer: A feasibility study. GASTROENTEROLOGY vol. 122, (4) A495-A495.
Kocher HM, Steward M, Leather AJM et al.(2002). Randomized clinical trial assessing the side-effects of glyceryl trinitrate and diltiazem hydrochloride in the treatment of chronic anal fissure. Br J Surg vol. 89, (4) 413-417.
Kocher HMK, Patel AG, Benjamin IS(2002). World-wide trends in biliary tract cancer. GASTROENTEROLOGY vol. 122, (4) A569-A569.
Tekkis PP, Kocher HM, Kessaris N et al.(2002). Risk adjustment in oesophagogastric surgery: a comparison of Bayesian analysis and logistic regression. BRIT J SURG vol. 89, (3) 381-381.
Al-Ghnaniem R, Kocher HM, Patel AG(2002). Prediction of inflammation of the appendix at open and laparoscopic appendicectomy: findings and consequences. Eur J Surg vol. 168, (1) 4-7.
Kua KB, Kocher HM, Kelkar A et al.(2001). Effect of topical glyceryl trinitrate on anodermal blood flow in patients with chronic anal fissures. ANZ J Surg vol. 71, (9) 548-550.
Kocher HM, Linklater Y, Patel S et al.(2001). Epidemiological study of oesophageal and gastric cancer in south-east England. BRIT J SURG vol. 88, (9) 1249-1257.
Kocher HM, Al-Ghnaniem R, Patel AG(2001). Major intra-abdominal pathology missed at laparoscopic cholecystectomy (Br J Surg 2000; 87: 1434-5). Br J Surg vol. 88, (6)
Tekkis PP, Kocher HM, Kessaris N et al.(2001). How accurate is POSSUM and p-POSSUM in predicting mortality in emergency surgery and in old age?. BRIT J SURG vol. 88, 42-43.
Kelkar AP, Kocher HM, Makar AA et al.(2001). Extraction of retained gallstones from an abscess cavity: a percutaneous endoscopic technique. Surg Laparosc Endosc Percutan Tech vol. 11, (2) 129-130.
Kocher HM, Steward M, Leather AJ et al.(2001). Topical Glyceryl Tri-Nitrate [GTN] (0.2%) vs topical diltiazem (2%) in the treatment of chronic fissure-in-ano: A prospective double-blind randomised trial. GASTROENTEROLOGY vol. 120, (5) A130-A130.
Kocher HM, Codd J, Al-Nawab M et al.(2001). Differential expression of Ras isoforms in normal human pancreas: An in vivo immuno-histochemical analysis. GUT vol. 48, A70-A70.
Wong T, Kocher H, Kane P et al.(2001). Evaluation of endoscopic ultrasound versus helical computed tomography in the assessment of pancreatic masses: Results from a UK centre. GUT vol. 48, A65-A65.
Return to top